Active Ingredient(S)
(in each extended-release tablet)
Fexofenadine HCl, USP 60 mg
Pseudoephedrine HCl, USP 120 mg
The following Structured Product Label (SPL) was submitted to the FDA by Amerisource Bergen for the product Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride (NDC 46122-452). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient(s), purpose, uses, warnings, do not use, ask a doctor before use if you have, when using this product, stop use and ask doctor if, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
(in each extended-release tablet)
Fexofenadine HCl, USP 60 mg
Pseudoephedrine HCl, USP 120 mg
Antihistamine
Nasal Decongestant
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
| adults and children 12 years of age and over | take 1 tablet with a glass of water every 12 hours on an empty stomach; do not take more than 2 tablets in 24 hours |
| children under 12 years of age | do not use |
| adults 65 years of age and older | ask a doctor |
| consumers with kidney disease | ask a doctor |
colloidal silicon dioxide, croscarmellose sodium, dibasic calcium phosphate dihydrate, ethyl cellulose, ferric oxide yellow, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, stearic acid.
Call toll free 1-800-818-4555 weekdays
Distributed By AmerisourceBergen
1300 Morris Drive, Chesterbrook, PA 19087
GOOD
NEIGHBOR
PHARMACY®
Compare to Allegra-D® active ingredients**
NDC 46122-452-60
Original Prescription Strength
NON-DROWSY
12 HOUR
fexofenadine HCl 60 mg/antihistamine
pseudoephedrine HCl 120 mg/nasal decongestant
Extended-Release Tablets, USP
Indoor & Outdoor Allergies
Allergy & Congestion
Relief of:
20 Extended-Release Tablets
* Please review the disclaimer below.